Reports
Sale
Global Contrast Media Injectors Market Size, Share, Forecast: By Product Type: Injector Systems, Consumables; By Type: Single Head Injectors, Dual-Head Injectors, Syringe less Injectors; By Applications: Radiology, Interventional Cardiology, Interventional Radiology, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Contrast Media Injectors Market Outlook:
The global contrast media injectors market size was valued at USD 1.61 billion in 2023, driven by the rising number of cardiovascular disease and cancer accompanied with technological advancements and increasing investments in healthcare sector. The market size is anticipated to grow at a CAGR of 7.20% during the forecast period of 2024-2032 to achieve a value of USD 3.01 billion by 2032.
Contrast Media Injectors: Introduction
Contrast media, also known as contrast agents, are devices used to inject contrast agents into the patient’s body during any diagnostic imaging procedures, like computed tomography, MRI, and angiography, to increase the image quality through enhanced visibility of blood vessels, organs, or specific tissues. Contrast agent injector enhances the precision in the procedure by preventing against any undesirable formation of air emboli, caused by inappropriate contrast material injection. Devices used in the procedure are also diverse in nature offering single head, dual- head, and syringe less injectors to allow accurate and precise delivery of contrast agents.
Global Contrast Media Injectors Market Analysis
The rising number of cancer and cardiovascular diseases, accompanied by technological advancements and increasing investment by governmental and healthcare bodies, are some of the key factors contributing to the contrast media injectors market growth. Recent developments in the market showcased the involvement of IT-enabled contrast media injectors to avoid any human errors while performing this procedure. Involvement of automated injectors in the procedure not only control the amount of contrast used but will also offer a more personalized dosage for patients with the help of electronic medical record or other communication systems.
Global Contrast Media Injectors Market Segmentations
Based on segments, the market is divided into product type, type, applications, end user, and region.
Market Breakup by Product Type
- Injector Systems
- CT Injector Systems
- MRI Injector Systems
- Cardiovascular/Angiography Injector Systems
- Consumables
- Tubing
- Syringe
- Others
Market Breakup by Type
- Single Head Injectors
- Dual-Head Injectors
- Syringe less Injectors
Market Breakup by Applications
- Radiology
- Interventional Cardiology
- Interventional Radiology
- Others
Market Breakup by End User
- Hospitals
- Diagnostics Centres
- Ambulatory Surgery Centres
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Contrast Media Injectors Market Overview
Advances in medical science and technology have made contrast media a routine procedure in the field of diagnosis. Over the years, with rapid improvement in technology, these contrast injectors have also evolved from manual injectors to more sophisticated and precise automated injectors, also known as autoinjectors. These autoinjectors have the capability to control the volume of media injected, utilization rate and the flow of dosage to keep pace with the medical imaging scanners. These improvements have made these devices more reliable and efficient, leading to a higher contrast media injectors market demand. Growing awareness about the benefits of early diagnosis of diseases has also led to an increase in the use of contrast media injectors.
Among the regional markets, North America has been accounting for the largest contrast media injectors market share and is anticipated to continue leading the global market owing to the higher presence of key players.
Global Contrast Media Injectors Market: Competitor Landscape
The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model, along with giving a SWOT analysis. The report gives a detailed analysis of the following contrast media injector companies, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- General Electric
- Vivid Imaging Solutions
- Hilin Life Products, Inc.
- Jodas Expoim Pvt. Ltd.
- Lantheus
- Magnus Health
- TAEJOON PHARM
- Spago Nanomedical AB
- Guerbet
- Bracco
- Bayer AG
- Medtron AG
- NemotoKyorindo Co., Ltd.
- ulrich GmbH & Co. KG
- Sino Medical-Device Technology Co.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Type |
|
| Breakup by Applications |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Contrast Media Injectors Market Overview
3.1 Global Contrast Media Injectors Market Historical Value (2017-2023)
3.2 Global Contrast Media Injectors Market Forecast Value (2024-2032)
4 Global Contrast Media Injectors Market Landscape
4.1 Global Contrast Media Injectors Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Contrast Media Injectors Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Contrast Media Injectors Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Contrast Media Injectors Market Segmentation
6.1 Global Contrast Media Injectors Market by Product Type
6.1.1 Market Overview
6.1.2 Injector Systems
6.1.2.1 CT Injector Systems
6.1.2.2 MRI Injector Systems
6.1.2.3 Cardiovascular/Angiography Injector Systems
6.1.3 Consumables
6.1.3.1 Tubing
6.1.3.2 Syringe
6.1.3.3 Others
6.2 Global Contrast Media Injectors Market by Type
6.2.1 Market Overview
6.2.2 Single Head Injectors
6.2.3 Dual-Head Injectors
6.2.4 Syringe less Injectors
6.3 Global Contrast Media Injectors Market by Applications
6.3.1 Market Overview
6.3.2 Radiology
6.3.3 Interventional Cardiology
6.3.4 Interventional Radiology
6.3.5 Others
6.4 Global Contrast Media Injectors Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Diagnostics Centres
6.4.4 Ambulatory Surgery Centres
6.4.5 Others
6.5 Global Contrast Media Injectors Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Contrast Media Injectors Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Contrast Media Injectors Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Contrast Media Injectors Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Contrast Media Injectors Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Contrast Media Injectors Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 General Electric
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Vivid Imaging Solutions
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 Hilin Life Products, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 Jodas Expoim Pvt. Ltd.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 Lantheus
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 Magnus Health
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 TAEJOON PHARM
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 Spago Nanomedical AB
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 Guerbet
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Bracco
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
17.11 Bayer AG
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisition
17.11.5 Certifications
17.12 Medtron AG
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisition
17.12.5 Certifications
17.13 NemotoKyorindo Co., Ltd.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisition
17.13.5 Certifications
17.14 ulrich GmbH & Co. KG
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisition
17.14.5 Certifications
17.15 Sino Medical-Device Technology Co.
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisition
17.15.5 Certifications
18 Global Contrast Media Injectors Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of USD 1.61 billion in 2023.
The market size is anticipated to grow at a CAGR of 7.20% during the forecast period of 2024-2032 to attain a value of around USD 3.01 billion by 2032, attributable to rising number of cardiovascular diseases and cancer cases, accompanied with technological advancements and increasing investments in healthcare sector.
Major contributors to the growth of the market include the rising number of cardiovascular diseases and cancer cases, accompanied with technological advancements and increasing investments in healthcare sector.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Among these regions, North America has been leading the global market and is likely to continue dominating the global market.
The different product types present in the market include injector systems and consumables. Injector systems include CT, MRI, and cardiovascular/angiography and consumables include tubing and syringe, among others.
The different types of products in the market are single head, dual-head, and syringe less injectors.
The product finds wide applications in radiology, interventional cariology, and interventional radiology, among others.
The end users of the product include hospital, diagnostic centres, and ambulatory surgery centres, among others.
Major trends that are responsible for the growth of this market are the rising number of cancer and cardiovascular diseases accompanied by technological advancements and increasing investment by governmental and healthcare bodies.
Key players involved in the market includes General Electric, Vivid Imaging Solutions, Hilin Life Products, Inc., Jodas Expoim Pvt. Ltd., Lantheus, Magnus Health, TAEJOON PHARM, Spago Nanomedical AB, Guerbet, Bracco, Bayer AG, Medtron AG, NemotoKyorindo Co., Ltd., ulrich GmbH & Co. KG, Sino Medical-Device Technology Co.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER